Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenon Medical (TNON) Gains from Investment Securities (2021 - 2025)

Historic Gains from Investment Securities for Tenon Medical (TNON) over the last 5 years, with Q3 2025 value amounting to $77150.0.

  • Tenon Medical's Gains from Investment Securities rose 41231.82% to $77150.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $77150.0, marking a year-over-year increase of 41231.82%. This contributed to the annual value of $21309.0 for FY2024, which is 6677.62% up from last year.
  • Latest data reveals that Tenon Medical reported Gains from Investment Securities of $77150.0 as of Q3 2025, which was up 41231.82% from $77150.0 recorded in Q2 2025.
  • Over the past 5 years, Tenon Medical's Gains from Investment Securities peaked at $119351.0 during Q2 2024, and registered a low of -$77000.0 during Q4 2022.
  • Moreover, its 5-year median value for Gains from Investment Securities was $48404.5 (2023), whereas its average is $42084.2.
  • Over the last 5 years, Tenon Medical's Gains from Investment Securities had its largest YoY gain of 41231.82% in 2025, and its largest YoY loss of 3535.87% in 2025.
  • Over the past 5 years, Tenon Medical's Gains from Investment Securities (Quarter) stood at $1000.0 in 2021, then tumbled by 7800.0% to -$77000.0 in 2022, then soared by 116.59% to $12777.0 in 2023, then surged by 66.78% to $21309.0 in 2024, then surged by 262.05% to $77150.0 in 2025.
  • Its Gains from Investment Securities stands at $77150.0 for Q3 2025, versus $77150.0 for Q2 2025 and $77150.0 for Q1 2025.